If you build it, they will run : the role of clinical trial infrastructure in neglected disease R&D
Name
1051454066-MIT.pdf
Description
Full printable version
Size
3.16 MB
Format
Adobe PDF
Checksum (MD5)
bb2740d2dfc498a2fbecb55d9ebd753b
Author(s)
Fry, Caroline Viola
Advisor(s)
Pierre Azoulay.
Alternative Title
Role of clinical trial infrastructure in neglected disease Research and Development
Date Issued
2018
Publisher
Massachusetts Institute of Technology
Abstract
I investigate the role of country level clinical trial infrastructure on research and development (R&D) levels for neglected tropical diseases concentrated in those countries. Pre-existing clinical trial infrastructure in a location can affect the cost and time of clinical trials carried out there, thus influence returns on investments for diseases that are located in different places. Using a newly constructed dataset I assess the components that make up a country's clinical trial infrastructure, which varies for countries in different stages of development. Using data on neglected tropical disease global disease burdens and research levels, I find that the level of R&D into diseases concentrated in countries with poorer clinical trial infrastructure is lower than that for diseases concentrated in countries with better infrastructure. This paper suggests a need for further work into the role of research infrastructure in developing countries and its role on innovation outcomes for issues affecting the world's poorest countries.
Description
Thesis: S.M. in Management Research, Massachusetts Institute of Technology, Sloan School of Management, 2018.
Cataloged from PDF version of thesis.
Includes bibliographical references (pages 21-22).
Subjects
Sloan School of Management.
MIT Department
Sloan School of Management
Terms of Use
MIT theses are protected by copyright. They may be viewed, downloaded, or printed from this source but further reproduction or distribution in any format is prohibited without written permission.
Persistent DSpace Link
